Hosier, Gregory W., and Naji J. Touma. 2017. “Response of Renal Cell Carcinoma to Ibrutinib, a Bruton Tyrosine Kinase Inhibitor, in a Patient Treated for Chronic Lymphocytic Leukemia”. Canadian Urological Association Journal 11 (5):E237-9. https://doi.org/10.5489/cuaj.4316.